Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 2
2020 3
2021 8
2022 13
2023 27
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Longitudinal feasibility of the Montreal Cognitive Assessment (MoCA) in non-demented ALS patients.
Aiello EN, Solca F, Torre S, Colombo E, Maranzano A, De Lorenzo A, Patisso V, Treddenti M, Curti B, Morelli C, Doretti A, Verde F, Ferrucci R, Barbieri S, Ruggiero F, Priori A, Silani V, Ticozzi N, Poletti B. Aiello EN, et al. Among authors: colombo e. Eur Neurol. 2024 Apr 20. doi: 10.1159/000538828. Online ahead of print. Eur Neurol. 2024. PMID: 38643758
An exploratory study on counterfactual thinking in amyotrophic lateral sclerosis.
Poletti B, Aiello EN, Tagini S, Solca F, Torre S, Colombo E, Maranzano A, Bonetti R, Schevegher F, Morelli C, Doretti A, Verde F, Barbieri S, Mameli F, Priori A, Ferrucci R, Silani V, Cherubini P, Pravettoni G, Ticozzi N. Poletti B, et al. Among authors: colombo e. Front Psychol. 2023 Dec 4;14:1281976. doi: 10.3389/fpsyg.2023.1281976. eCollection 2023. Front Psychol. 2023. PMID: 38111871 Free PMC article.
A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial.
Lombardo FL, Spila Alegiani S, Mayer F, Cipriani M, Lo Giudice M, Ludolph AC, McDermott CJ, Corcia P, Van Damme P, Van den Berg LH, Hardiman O, Nicolini G, Vanacore N, Dickie B, Albanese A, Puopolo M; TUDCA-ALS Study Group. Lombardo FL, et al. Trials. 2023 Dec 5;24(1):792. doi: 10.1186/s13063-023-07638-w. Trials. 2023. PMID: 38053196 Free PMC article. Clinical Trial.
Tetraphenylethylene-Based Photoluminescent Self-Assembled Nanoparticles: Preparation and Biological Evaluation.
Colombo E, Aydın EM, Canıtez İS, Polito L, Penconi M, Bossi A, Impresari E, Passarella D, Dallavalle S, Athanassopoulos CM, Pellegrino S, Şahin ID, Christodoulou MS. Colombo E, et al. ACS Med Chem Lett. 2023 Sep 29;14(10):1472-1477. doi: 10.1021/acsmedchemlett.3c00396. eCollection 2023 Oct 12. ACS Med Chem Lett. 2023. PMID: 37849561 Free PMC article.
The impact of upper motor neuron involvement on clinical features, disease progression and prognosis in amyotrophic lateral sclerosis.
Colombo E, Gentile F, Maranzano A, Doretti A, Verde F, Olivero M, Gagliardi D, Faré M, Meneri M, Poletti B, Maderna L, Corti S, Corbo M, Morelli C, Silani V, Ticozzi N. Colombo E, et al. Front Neurol. 2023 Sep 26;14:1249429. doi: 10.3389/fneur.2023.1249429. eCollection 2023. Front Neurol. 2023. PMID: 37822527 Free PMC article.
The value of routine blood work-up in clinical stratification and prognosis of patients with amyotrophic lateral sclerosis.
Gentile F, Maranzano A, Verde F, Bettoni V, Colombo E, Doretti A, Olivero M, Scheveger F, Colombrita C, Bulgarelli I, Spinelli EG, Torresani E, Messina S, Maderna L, Agosta F, Morelli C, Filippi M, Silani V, Ticozzi N. Gentile F, et al. Among authors: colombo e. J Neurol. 2024 Feb;271(2):794-803. doi: 10.1007/s00415-023-12015-3. Epub 2023 Oct 6. J Neurol. 2024. PMID: 37801095 Free PMC article.
Frontotemporal-spectrum disorders and functional independence in non-demented ALS patients.
Aiello EN, Solca F, Torre S, Gentile F, Scheveger F, Olivero M, Colombo E, Maranzano A, Manzoni M, Morelli C, Doretti A, Verde F, Silani V, Ticozzi N, Poletti B. Aiello EN, et al. Among authors: colombo e. Neurol Sci. 2024 Mar;45(3):1087-1095. doi: 10.1007/s10072-023-07074-3. Epub 2023 Sep 29. Neurol Sci. 2024. PMID: 37773576 Free PMC article.
Cognitive rehabilitation and aerobic exercise for cognitive impairment in people with progressive multiple sclerosis (CogEx): a randomised, blinded, sham-controlled trial.
Feinstein A, Amato MP, Brichetto G, Chataway J, Chiaravalloti ND, Cutter G, Dalgas U, DeLuca J, Farrell R, Feys P, Filippi M, Freeman J, Inglese M, Meza C, Motl RW, Rocca MA, Sandroff BM, Salter A; CogEx Research Team. Feinstein A, et al. Lancet Neurol. 2023 Oct;22(10):912-924. doi: 10.1016/S1474-4422(23)00280-6. Lancet Neurol. 2023. PMID: 37739574 Clinical Trial.
49 results